Dr. Amin Daemi is a biochemist hailing from Cukurova University of Medical Sciences in Turkey. His research encompasses diverse areas including the design of recombinant vaccines utilizing heat shock proteins and electroporation, notably pioneering the design, cloning, and production of HPV16E7CT (gp96) protein. He has also delved into areas such as diabetic wound healing, oxidative stress, plant extracts, and the development of a novel type of anti-angiogenesis molecular antibody. Dr. Daemi has also been active in utilizing nanoparticles in disease diagnosis and has investigated TPMT enzyme variants in inflammatory bowel diseases. Dr. Daemi's expertise has also been recognized through his roles as an editorial board member and referee for various medical journals.